Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion
This study has been terminated.
Study NCT00969293   Information provided by Fovea Pharmaceuticals SA

First Received on August 31, 2009.   Last Updated on January 9, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial